SCHEMBL1824065

SCHEMBL1824065

CS(=O)(=O)Cc1cccc(NC(=O)C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.57
PDK1 Q15118 2/20 0.52
PDK2 Q15119 2/20 0.52
PDK3 Q15120 2/20 0.52
PDK4 Q16654 2/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.52
PARP1 P09874 1/20 0.48
CYP2C19 P33261 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818773 0.86 L3MBTL1 (0.55) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL1820483 0.84 LMNA (0.54) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL15601887 0.82 HDAC3 (0.72) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL28182250 0.80 PDK1 (0.71) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL14041043 0.80 L3MBTL1 (0.61) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL27673183 0.79 L3MBTL1 (0.59) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL7276139 0.79 L3MBTL1 (0.59) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL20724726 0.79 NPY1R (0.45) PDK1PDK2PDK3PDK4LMNA
SCHEMBL1817463 0.78 L3MBTL1 (0.58) L3MBTL1PDK1PDK2PDK3PDK4
SCHEMBL1819254 0.78 L3MBTL1 (0.58) L3MBTL1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461134-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-14 US disclosed
WO-2011060196-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD L3MBTL1 270/4885PDK1 4272/4885PDK2 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.